In a breakthrough research finding, the Hyderabad based scientists at Council of Scientific and Industrial Research (CSIR) have a new drug to treat the rare form of skin cancer Melanoma.
The new finding by the scientists is considered to be an important development as they have made positive advancements in developing a possible therapeutic drug that could cure melanoma. Melanoma is a rare form of skin cancer which is more dangerous than other form of skin cancer.
Scientists, from both Indian Institute of Chemical Technology (IICT) and Indian Institute Of Chemical Biology (IICB) have been working on a research since long and recently brought to light their research findings where they claimed to have developed a synthetic transcription factor composed of peptide molecule that showed promising results in animals to treat the rare form of melanoma skin cancer.
At present the scientists have conducted clinical trials only on animals and have found positive results. The next step is to check the safety and efficacy of the drug in humans. “Animal testing of these peptide molecules has shown no toxicity. But only after human trial, we can tell if they have any side-effects or not,” explains Prof. Siddhartha Roy, director IICB.
Optimistic Roy also points that the new creation may also prove to be the way cancers are treated in future and felt that it will take a few more years to establish something concrete. While referring to clinical trials of the new drug in humans, Roy said, “Currently IICB has collaborated with the Mayo clinic in Minnesota in the US and we are optimistic that it will happen as soon as patent for the said drug is given.”
Talking about the clinical trials in India, Roy opined that it is difficult to conduct trials in India as the present Indian industry is not so well developed to carry out advanced clinical trials.
Source:Pharmabiz
The new finding by the scientists is considered to be an important development as they have made positive advancements in developing a possible therapeutic drug that could cure melanoma. Melanoma is a rare form of skin cancer which is more dangerous than other form of skin cancer.
Scientists, from both Indian Institute of Chemical Technology (IICT) and Indian Institute Of Chemical Biology (IICB) have been working on a research since long and recently brought to light their research findings where they claimed to have developed a synthetic transcription factor composed of peptide molecule that showed promising results in animals to treat the rare form of melanoma skin cancer.
At present the scientists have conducted clinical trials only on animals and have found positive results. The next step is to check the safety and efficacy of the drug in humans. “Animal testing of these peptide molecules has shown no toxicity. But only after human trial, we can tell if they have any side-effects or not,” explains Prof. Siddhartha Roy, director IICB.
Optimistic Roy also points that the new creation may also prove to be the way cancers are treated in future and felt that it will take a few more years to establish something concrete. While referring to clinical trials of the new drug in humans, Roy said, “Currently IICB has collaborated with the Mayo clinic in Minnesota in the US and we are optimistic that it will happen as soon as patent for the said drug is given.”
Talking about the clinical trials in India, Roy opined that it is difficult to conduct trials in India as the present Indian industry is not so well developed to carry out advanced clinical trials.
Source:Pharmabiz
No comments:
Post a Comment